“…The present study showed that flavonoid-rich ChrSd supplementation significantly down-regulated the expression of genes related to oxidative stress, innate immune and inflammatory responses; i.e., regulation of nitric-oxide synthase activity (Nostrin and Nos2). In addition, ChrSd supplementation downregulated the expression of genes encoding adipogenic factors such as Gdf3 (Andersson, Korach-Andre, Reissmann, Ibanez, & Bertolino, 2008), Gpd1, Cebpb, Lep (Kim et al, 2014), Tgfb1, Tgfbr1 (Yadav et al, 2011), and Lmna (Lelliott et al, 2002), and genes involved in fatty acid synthesis (Elovl1), while it up-regulated genes for fatty acid β-oxidation (Ppara and Echdc2), leading to reduced HF-induced obesity. This alteration in adipose tissue was accompanied by a significantly lower total body weight and improved HF-induced insulin resistance and glucose intolerance, as compared to the control group.…”